Elite Pharmaceuticals, Inc. (ELTP)

Elite Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	470	157	29	35	62	61
Market Cap Growth	306.60%	434.24%	-16.81%	-42.59%	1.75%	-25.71%
Enterprise Value	473	159	27	31	61	76
Last Close Price	0.44	0.15	0.03	0.03	0.06	0.07
PE Ratio	-	7.81	8.26	3.97	12.10	-
PS Ratio	6.64	2.77	0.86	1.10	2.42	3.36
PB Ratio	12.90	2.73	1.01	1.40	3.81	5.68
P/TBV Ratio	15.99	2.74	1.03	1.43	3.92	-
P/FCF Ratio	108.91	-	-	5.88	21.50	-
P/OCF Ratio	103.39	-	8.81	5.43	19.27	-
EV/Sales Ratio	6.76	2.81	0.80	0.96	2.40	4.25
EV/EBITDA Ratio	32.81	13.14	5.25	4.94	17.86	-
EV/EBIT Ratio	38.85	14.75	6.92	6.11	28.90	-
EV/FCF Ratio	109.60	-	-	5.15	21.24	-
Debt / Equity Ratio	0.31	0.20	0.13	0.11	0.15	0.38
Debt / EBITDA Ratio	0.78	0.96	0.73	0.43	0.66	-
Debt / FCF Ratio	2.61	-	-	0.46	0.83	-
Asset Turnover	0.85	0.91	0.90	1.05	0.99	0.73
Inventory Turnover	2.27	2.69	2.16	2.97	2.95	2.31
Quick Ratio	1.82	2.04	1.40	1.73	1.15	0.61
Current Ratio	3.27	3.07	2.75	2.82	2.10	1.19
Return on Equity (ROE)	-43.41%	46.47%	13.15%	43.01%	37.96%	-20.32%
Return on Assets (ROA)	9.20%	10.83%	6.52%	10.33%	5.14%	-5.79%
Return on Capital (ROIC)	14.92%	13.20%	8.15%	13.62%	7.92%	-9.50%
Return on Capital Employed (ROCE)	16.00%	15.30%	12.00%	17.80%	10.30%	-
Earnings Yield	-3.83%	12.80%	12.11%	25.18%	8.27%	-3.70%
FCF Yield	0.92%	-2.60%	-8.15%	17.00%	4.65%	-3.02%
Buyback Yield / Dilution	-3.71%	-1.02%	-0.23%	-7.17%	5.06%	-21.68%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.